Melasma
119
8
11
56
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Research Maturity
56 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
5 terminated out of 119 trials
91.8%
+5.3% vs benchmark
20%
24 trials in Phase 3/4
9%
5 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 56 completed trials
Clinical Trials (119)
Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma
Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma
Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma
Study of the Influence of Blue Light Emitted by Computer / Television Screens on Melasma MELABLUE Study
Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma
Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma
Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions
Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma
Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi
Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma
Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study
Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.
Treatment and Prevention of Melasma Relapses by Using 1064nm 650 Microsecond Laser
Secretome TGF Beta 3
Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES
Efficacy and Safety of 30% Salicylic Acid and 10% Nicotinamide Combined Therapy in Melasma
Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration